Insider · CIK 0001678149

Olson Eric R

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001678149

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-17	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−689 sh	$3.50	−$2,411.5	6,661
2023-04-03	Syros Pharmaceuticals, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−623 sh	$2.58	−$1,607.34	7,350
2023-03-31	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,000 sh	—	—	7,973
2023-03-31	Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,000 sh	—	—	6,000
2023-02-16	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+35K sh	—	—	35,000
2022-10-06	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+44.5K sh	—	—	44,500
2022-10-06	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+34K sh	—	—	34,000
2022-04-01	Syros Pharmaceuticals, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−27.3K sh	$1.12	−$30.5K	59,734
2022-02-15	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+100K sh	—	—	100,000
2022-02-15	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2022-02-15	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+200K sh	—	—	200,000
2022-01-05	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,208 sh	$3.47	−$7,654.915	0
2021-07-01	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,164 sh	$5.55	−$6,460.2	0
2021-03-15	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,628 sh	$1.01	+$3,664.28	3,628
2021-03-15	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,628 sh	$9.47	−$34.4K	0
2021-03-15	Syros Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,628 sh	—	—	90,697
2021-02-17	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+94K sh	—	—	94,000
2020-08-18	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10.8K sh	$1.01	+$10.9K	10,787
2020-08-18	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−10.8K sh	$13.00	−$140K	0
2020-08-18	Syros Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10.8K sh	—	—	94,325
2020-08-17	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,963 sh	$1.01	+$5,012.63	4,963
2020-08-17	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−4,963 sh	$13.00	−$64.5K	0
2020-08-17	Syros Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,963 sh	—	—	105,112
2020-07-07	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,753 sh	$11.72	−$20.5K	0
2020-02-18	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,446 sh	$7.38	−$10.7K	0
2020-02-13	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+94K sh	—	—	94,000
2019-02-12	Syros Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+87K sh	—	—	87,000
2019-02-12	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+75K sh	—	—	75,000
2018-02-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+75K sh	—	—	75,000
2017-08-07	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,500 sh	$1.01	+$2,525	2,500
2017-08-07	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,500 sh	$23.59	−$59K	0
2017-08-07	Syros Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,500 sh	—	—	110,075
2017-07-25	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+12.5K sh	$1.01	+$12.6K	12,500
2017-07-25	Syros Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−12.5K sh	$21.85	−$273K	0
2017-07-25	Syros Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+12.5K sh	—	—	25,025
2017-02-10	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+63.5K sh	—	—	63,500

Recent filings

Accepted (ET)
Jul 184
Olson Eric R0001209191-23-042669
SEC(opens sec.gov)
Apr 44
Olson Eric R0001209191-23-022970
SEC(opens sec.gov)
Feb 214
Olson Eric R0001209191-23-011165
SEC(opens sec.gov)
Oct 114
Olson Eric R0001209191-22-053319
SEC(opens sec.gov)
Apr 44
Olson Eric R0001209191-22-022503
SEC(opens sec.gov)
Feb 174
Olson Eric R0001209191-22-010710
SEC(opens sec.gov)
Jan 64
Olson Eric R0001209191-22-002216
SEC(opens sec.gov)
Jul 14
Olson Eric R0001209191-21-044493
SEC(opens sec.gov)
Mar 174
Olson Eric R0001209191-21-021428
SEC(opens sec.gov)
Feb 194
Olson Eric R0001209191-21-012337
SEC(opens sec.gov)
Aug 194
Olson Eric R0001209191-20-047504
SEC(opens sec.gov)

Companies

Syros Pharmaceuticals, Inc.Chief Scientific Officer

Address

C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE, SUITE 300

CAMBRIDGE, MA, 02139